중환자실 재원 중 발생한 급성 신손상의 위험인자 평가
Evaluation of Risk Factors for Acute Renal Injury in Critically Ill Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Acute kidney injury (AKI) is an abrupt loss of kidney function. Specifically, AKI occurring in intensive care units (ICU) is associated with increased mortality, morbidity, and length of hospital stay. Therefore, prevention and early treatment of AKI is important. This study analyzed the risk factors and prognosis of AKI in the ICU and evaluated correlations between the use of nephrotoxic drugs and the occurrence of AKI. Methods : In this retrospective study, patients who were treated more than 48 hours in the medical intensive care unit from March 2015 to June 2015, were included. Those who had received dialysis and had chronic kidney disease (CKD) stage 5 upon admission were excluded. AKI was defined as an increase in serum creatinine more than 150% from baseline, according to RIFLE (Risk, Injury, Failure, Loss of kidney function and End-stage kidney disease) criteria. The patients were divided into two groups, the AKI group and the non-AKI group. Risk factors were analyzed by comparing such factors as underlying diseases and the use of nephrotoxic drugs in both groups. Results : A total of 148 patients met the inclusion criteria and were included in the analysis. AKI occurred in 69 patients (46.6%). The frequencies of sepsis, chronic obstructive pulmonary disease (COPD), and adult respiratory distress syndrome (ARDS), and the use of amphotericin B, colistin, vasopressors, and diuretics were significantly greater in the AKI group than in the non-AKI group (p 0.05). The number of concomitant nephrotoxic drugs used by patients in the AKI group was greater than in the non-AKI group. Significant effects of sepsis and colistin were confirmed with multiple regression analysis (p=0.020, p=0.005). Twenty-six patients in the AKI group recovered and the average recovery period was 8.8 days. Conclusions : AKI is a relatively common disease in ICU patients. Sepsis and use of colistin were shown to be important risk factors of AKI. Based on the results of this study, we suggest that active intervention by pharmacists is important for patients with these risk factors.
Abstract
Background : Acute kidney injury (AKI) is an abrupt loss of kidney function. Specifically, AKI occurring in intensive care units (ICU) is associated with increased mortality, morbidity, and length of hospital stay. Therefore, prevention and early treatment of AKI is important. This study analyzed the risk factors and prognosis of AKI in the ICU and evaluated correlations between the use of nephrotoxic drugs and the occurrence of AKI. Methods : In this retrospective study, patients who were treated more than 48 hours in the medical intensive care unit from March 2015 to June 2015, were included. Those who had received dialysis and had chronic kidney disease (CKD) stage 5 upon admission were excluded. AKI was defined as an increase in serum creatinine more than 150% from baseline, according to RIFLE (Risk, Injury, Failure, Loss of kidney function and End-stage kidney disease) criteria. The patients were divided into two groups, the AKI group and the non-AKI group. Risk factors were analyzed by comparing such factors as underlying diseases and the use of nephrotoxic drugs in both groups. Results : A total of 148 patients met the inclusion criteria and were included in the analysis. AKI occurred in 69 patients (46.6%). The frequencies of sepsis, chronic obstructive pulmonary disease (COPD), and adult respiratory distress syndrome (ARDS), and the use of amphotericin B, colistin, vasopressors, and diuretics were significantly greater in the AKI group than in the non-AKI group (p 0.05). The number of concomitant nephrotoxic drugs used by patients in the AKI group was greater than in the non-AKI group. Significant effects of sepsis and colistin were confirmed with multiple regression analysis (p=0.020, p=0.005). Twenty-six patients in the AKI group recovered and the average recovery period was 8.8 days. Conclusions : AKI is a relatively common disease in ICU patients. Sepsis and use of colistin were shown to be important risk factors of AKI. Based on the results of this study, we suggest that active intervention by pharmacists is important for patients with these risk factors.
참고문헌 (22)
- Nisula S, "Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units : the FINNAKI study", Intensive Care Med, 39(3), pp.420~428 (2013)
- Siew ED, "The growth of acute kidney injury : a rising tide or just closer attention to detail?", Kidney Int, 87(1), pp.46~61 (2015)
- De Mendonca A, "Acute renal failure in the ICU : risk factors and outcome evaluated by the SOFA score", Intensive Care Med, 26(7), pp.915~921 (2000)
- Chertow GM, "Acute kidney injury, mortality, length of stay, and costs in hospitalized patients", J Am Soc Nephrol, 16(11), pp.3365~3370 (2005)
- Joannidis M, "Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM", Intensive Care Med, 36(3), pp.392~411 (2010)
- Naughton CA, "Drug-induced nephrotoxicity", Am Fam Physician, 78(6), pp.743~750 (2008)
- Perazella MA, "Drug use and nephrotoxicity in the intensive care unit", Kidney International, 81(12), pp.1172~1178 (2012)
- Singbartl K, "AKI in the ICU : definition, epidemiology, risk stratification, and outcomes", Kidney Int, 81(9), pp.819~825 (2012)
- Rocco M, "Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and", or other nephrotoxic antibiotics: a retrospective cohort study, 2013, pp.17(4), R174~
- Nash K, "Hospital-acquired renal insufficiency", Am J Kidney Dis, 39(5), pp.930~936 (2002)
- Schrier RW, "Acute renal failure and sepsis", N Engl J Med, 351(2), pp.159~169 (2004)
- Pankhurst T, "Acute kidney injury following unselected emergency admission : role of the inflammatory response, medication and co-morbidity", Nephron Clin Pract, 126(1), pp.81~89 (2014)
- Bagshaw SM, "Early acute kidney injury and sepsis: a multicentre evaluation", Crit Care, 12, pp.R47~ (2008)
- Markowitz GS, "Drug-induced renal failure: a focus on tubulointerstitial disease", Clin Chim Acta, 351(1-2), pp.31~47 (2005)
- Uchino S, "Acute renal failure in critically ill patients : a multinational, multicenter study", JAMA, 294(7), pp.813~818 (2005)
- Bonventre JV, "Diagnosis of acute kidney injury : from classic parameters to new biomarkers", Contrib Nephrol, 156, pp.213~219 (2007)
- Prowle JR, "Measurement of AKI biomarkers in the ICU : still striving for appropriate clinical indications", Intensive Care Med, 41(3), pp.541~543 (2015)
- Tan HL, "Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure", Blood Purif, 41(1-3), pp.144~150 (2016)
- Han WK, "Kidney Injury Molecule-1(KIM-1) : a novel biomarker for human renal proximal tubule injury", Kidney Int, 62(1), pp.237~244 (2002)
- Martensson J, "Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients", Ann Intensive Care, 6, pp.6~ (2016)
- Schetz M, "Druginduced acute kidney injury", Curr Opin Crit Care, 11(6), pp.555~565 (2005)
- Perazella MA, "Crystal-induced acute renal failure", Am J Med, 106(4), pp.459~465 (1999)